GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 908 Devices Inc (NAS:MASS) » Definitions » Piotroski F-Score
中文

908 Devices (908 Devices) Piotroski F-Score : 3 (As of Apr. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is 908 Devices Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

908 Devices has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for 908 Devices's Piotroski F-Score or its related term are showing as below:

MASS' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 3   Max: 3
Current: 3

During the past 6 years, the highest Piotroski F-Score of 908 Devices was 3. The lowest was 3. And the median was 3.


908 Devices Piotroski F-Score Historical Data

The historical data trend for 908 Devices's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

908 Devices Piotroski F-Score Chart

908 Devices Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 3.00 3.00 3.00

908 Devices Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.00 3.00 3.00 3.00

Competitive Comparison of 908 Devices's Piotroski F-Score

For the Medical Devices subindustry, 908 Devices's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


908 Devices's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where 908 Devices's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -12.532 + -9.346 + -7.093 + -7.429 = $-36.40 Mil.
Cash Flow from Operations was -10.647 + -7.882 + -4.6 + -1.93 = $-25.06 Mil.
Revenue was 9.487 + 12.094 + 14.297 + 14.351 = $50.23 Mil.
Gross Profit was 4.384 + 5.794 + 7.869 + 7.275 = $25.32 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(242.587 + 218.407 + 210.83 + 208.475 + 202.981) / 5 = $216.656 Mil.
Total Assets at the begining of this year (Dec22) was $242.59 Mil.
Long-Term Debt & Capital Lease Obligation was $3.93 Mil.
Total Current Assets was $173.79 Mil.
Total Current Liabilities was $22.55 Mil.
Net Income was -9.415 + -8.099 + -6.259 + -9.791 = $-33.56 Mil.

Revenue was 8.306 + 11.106 + 15.797 + 11.643 = $46.85 Mil.
Gross Profit was 4.129 + 6.634 + 9.338 + 5.922 = $26.02 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(260.906 + 251.226 + 246.995 + 249.281 + 242.587) / 5 = $250.199 Mil.
Total Assets at the begining of last year (Dec21) was $260.91 Mil.
Long-Term Debt & Capital Lease Obligation was $18.04 Mil.
Total Current Assets was $215.63 Mil.
Total Current Liabilities was $19.23 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

908 Devices's current Net Income (TTM) was -36.40. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

908 Devices's current Cash Flow from Operations (TTM) was -25.06. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-36.4/242.587
=-0.15004926

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-33.564/260.906
=-0.12864403

908 Devices's return on assets of this year was -0.15004926. 908 Devices's return on assets of last year was -0.12864403. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

908 Devices's current Net Income (TTM) was -36.40. 908 Devices's current Cash Flow from Operations (TTM) was -25.06. ==> -25.06 > -36.40 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=3.929/216.656
=0.01813474

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=18.04/250.199
=0.07210261

908 Devices's gearing of this year was 0.01813474. 908 Devices's gearing of last year was 0.07210261. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=173.79/22.549
=7.7072154

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=215.626/19.226
=11.2153334

908 Devices's current ratio of this year was 7.7072154. 908 Devices's current ratio of last year was 11.2153334. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

908 Devices's number of shares in issue this year was 32.443. 908 Devices's number of shares in issue last year was 31.645. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=25.322/50.229
=0.50413108

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=26.023/46.852
=0.55542986

908 Devices's gross margin of this year was 0.50413108. 908 Devices's gross margin of last year was 0.55542986. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=50.229/242.587
=0.20705561

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=46.852/260.906
=0.17957425

908 Devices's asset turnover of this year was 0.20705561. 908 Devices's asset turnover of last year was 0.17957425. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

908 Devices has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

908 Devices  (NAS:MASS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


908 Devices Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of 908 Devices's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


908 Devices (908 Devices) Business Description

Traded in Other Exchanges
N/A
Address
645 Summer Street, Boston, MA, USA, 02210
908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.
Executives
Griffith Joseph H. Iv officer: Chief Financial Officer 68 ELM STREET, HOPKINTON MA 01748
Christopher D. Brown officer: Chief Technology Officer C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Kevin J. Knopp director, officer: President and CEO C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Michael S. Turner officer: VP, General Counsel C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Maura Fitzpatrick officer: VP, Product Management & Mktg 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Mark Spoto director C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Michele Fournier officer: Chief People Officer 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Trent A. Basarsky officer: Vice President, Commercial C/O PROTEINSIMPLE, 3040 OAKMEAD VILLAGE DRIVE, SANTA CLARA CA 95051
John Kenneweg officer: Vice President, Government C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Anthony Hunt director 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02452
Nicolas Barthelemy director 1750 BELLA LAGUNA CT, ENCINITAS CA 92024
Marcia Eisenberg director C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Jeffrey P. George director C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER NJ 08807
Fenel M Eloi director C/O INTERLEUKIN GENETICS INC, 135 BEAVER STREET, WALTHAM MA 02452
Keith Crandell director, 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631